209 related articles for article (PubMed ID: 8023963)
1. The emerging role of transforming growth factor-beta in kidney diseases.
Sharma K; Ziyadeh FN
Am J Physiol; 1994 Jun; 266(6 Pt 2):F829-42. PubMed ID: 8023963
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in kidney disease: the role of transforming growth factor-beta.
Border WA; Noble NA
Am J Kidney Dis; 1993 Jul; 22(1):105-13. PubMed ID: 8322771
[TBL] [Abstract][Full Text] [Related]
3. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
Witowski J; Knapowski J
Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
Bruijn JA; Roos A; de Geus B; de Heer E
J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
[TBL] [Abstract][Full Text] [Related]
5. In vivo interactions of TGF-beta and extracellular matrix.
Noble NA; Harper JR; Border WA
Prog Growth Factor Res; 1992; 4(4):369-82. PubMed ID: 1340215
[TBL] [Abstract][Full Text] [Related]
6. [TGF-beta: usage in nephrology].
Quirin N; Feige JJ; Zaoui P
Nephrologie; 1996; 17(4):227-35. PubMed ID: 8768454
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta and the pathogenesis of glomerular diseases.
Border WA
Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):54-8. PubMed ID: 7850412
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?
Ketteler M; Noble NA; Border WA
Annu Rev Physiol; 1995; 57():279-95. PubMed ID: 7778869
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
Verrecchia F; Mauviel A
J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
[TBL] [Abstract][Full Text] [Related]
11. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis.
Border WA; Noble NA
Hypertension; 1998 Jan; 31(1 Pt 2):181-8. PubMed ID: 9453300
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
13. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway.
Wolf G
Kidney Int; 2006 Dec; 70(11):1914-9. PubMed ID: 16985515
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
15. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
Chegini N
Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
[TBL] [Abstract][Full Text] [Related]
16. Kidney expression of RhoA, TGF-beta1, and fibronectin in human IgA nephropathy.
Mattii L; Segnani C; Cupisti A; D'Alessandro D; Moscato S; Meola M; Barsotti G; Marinò M; Bianchi F; Dolfi A; Bernardini N
Nephron Exp Nephrol; 2005; 101(1):e16-23. PubMed ID: 15925904
[TBL] [Abstract][Full Text] [Related]
17. Role of TGF-beta in pathogenesis of diabetic nephropathy.
Pantsulaia T
Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta in renal injury and disease.
Böttinger EP
Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
[TBL] [Abstract][Full Text] [Related]
19. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
20. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
